SigTuple Launches AS76, an Edge-AI Digital Morphology Analyzer for Peripheral Blood Smear Review Powered by NVIDIA

Bengaluru, India –  February 24,  2026  — SigTuple announced the launch of AS76, an AI-enabled digital morphology analyser designed to automate peripheral blood smear (PBS) microscopic review. AS76 combines automated digital microscopy with on-device, edge-AI computing to deliver faster, more consistent results while preserving data privacy.

Powered by NVIDIA RTX, the AS76 analyser will perform high-throughput image analysis using advanced AI models, all running locally on the device. This allows the system to deliver near-instant results even for large sample batches, without dependence on internet connectivity. 

An AI-powered automated digital microscope with built-in computing, AS76  system can load up to six PBS slides simultaneously, scan them in full diagnostic detail, and generate an AI-assisted report for expert review — with all processing performed entirely on the device. The system automates key elements of manual PBS review, including generation of a 200-cell leukocyte differential, highlighting red blood cell morphology, and flagging platelet morphology, including detection of platelet aggregates.

Equipped with 20×, 40×, and 100× objectives on an automated turret, AS76 launches with peripheral blood smear capabilities and is designed for future software upgrades to support tissues, fluids, bone marrow, and microbiology slides. This multi-application readiness positions AS76 as a digital replacement for the analog microscope in the laboratory.

By applying AI-driven cell pre-classification, AS76 standardizes smear review at scale and surfaces atypical findings quickly for expert confirmation. The system reduces manual effort and turnaround time. With all AI inference performed locally, AS76 eliminates latency, operates without internet connectivity, and ensures patient data remains within the laboratory. AS76 is CE-marked under IVDR, demonstrating compliance with European safety and performance requirements.

SigTuple’s AI-powered microscopy solutions have already demonstrated meaningful real-world impact, particularly in regions with limited access to specialist expertise. In remote and underserved areas, AI-enabled digital microscopy has enabled centralized pathologist review, timely diagnoses, and early detection of serious conditions that might otherwise go unnoticed. AS76 builds on this legacy, combining advanced imaging and edge AI to extend high-quality diagnostics to more laboratories and patients.

“Edge AI is the future of diagnostic microscopy,” said Tathagato Rai Dastidar, Founder & CEO of SigTuple. “With AS76, the intelligence stays where the data is generated, delivering near-instant analysis while preserving patient privacy. Labs gain speed and consistency, and patients gain confidentiality.”

“India’s AI startup ecosystem is primed for acceleration, driven by exceptional technical talent and global ambition,” said Tobias Halloran, Director of EMEAI Startups and Venture Capital at NVIDIA. “NVIDIA is accelerating this momentum by giving founders direct access to accelerated computing, scalable AI infrastructure, and programs like NVIDIA Inception for startups and the NVIDIA VC Alliance—helping startups scale faster and build for global markets.”

AS76 is available in select markets. To learn more or request a demonstration, visit https://as76.sigtuple.com/.